Psilocybe Cubensis mushrooms activate serotonin receptors in the pre-frontal cortex. They also affect perception, mood and cognition and can regulate arousal and panic response. However, they can also trigger disruptive visual hallucinations because psilocybin is a hallucinogenic compound.
The therapeutic potential of cultivating psilocybe cubensis spores is well known the United States. Psilocybe Cubensis mushrooms are often used to relieve symptoms of treatment-resistant depression and anxiety. They are also used to treat OCD and other mental health conditions. Moreover, they can protect against dementia and can help repair nerve damage. However, Psilocybe Cubensis is not beneficial to people suffering from psychosis or heart conditions.
Once ingested, psilocybin is converted into the active form psilocin which can help overcome fear conditioning and break traumatic cycles occurring in people suffering with PTSD. Moreover, it can treat mild and transient anxiety as well as help relieve the symptoms of other common types of anxiety including: separation anxiety, generalized anxiety disorder (GAD), panic disorders and social anxiety. Ultimately, it can also help treat addiction and death anxiety by increasing people’s sense of openness.
As a hallucinogen, psilocybin can temporarily disrupt communication between brain chemical systems and interfere with the action of serotonin that regulates sensory reception and mood. As a result, Psilocybe Cubensis mushrooms can reduce stress, promote cognitive health and improve sleep patterns.